Back to BlackRock, Inc. BlackRock, Inc.

TVTXTVTX
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in TRAVERE THERAPEUTICS INC

BlackRock, Inc. holds 8M shares of TVTX (TRAVERE THERAPEUTICS INC), worth $455.7M as of 2026-Q2. The position was increased (+2.9% shares). TVTX represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$455.7M

Current Shares

8M

Total Value Change

+$316M

Total Shares Change

+2,371

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
8M
+2.9%
$455.7M0.0%$56.81
32
2026-Q1
Decreased
7.8M
-1.0%
$231.5M0.0%$28.27
0
2025-Q4
Decreased
7.9M
-2.9%
$300.7M0.0%$37.68
0
2025-Q3
Decreased
8.1M
-0.8%
$193.6M0.0%$24.04
0
2025-Q2
Decreased
8.2M
-0.3%
$120.9M0.0%$14.77
0
2025-Q1
Increased
8.2M
+2.1%
$146.8M0.0%$19.68
31
2024-Q4
New
8M
-
$139.7M0.0%$17.32
42

Other major holders of TVTX: FMR LLC, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used